178 related articles for article (PubMed ID: 30473433)
21. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.
Moore CM; Kasivisvanathan V; Eggener S; Emberton M; Fütterer JJ; Gill IS; Grubb Iii RL; Hadaschik B; Klotz L; Margolis DJ; Marks LS; Melamed J; Oto A; Palmer SL; Pinto P; Puech P; Punwani S; Rosenkrantz AB; Schoots IG; Simon R; Taneja SS; Turkbey B; Ukimura O; van der Meulen J; Villers A; Watanabe Y;
Eur Urol; 2013 Oct; 64(4):544-52. PubMed ID: 23537686
[TBL] [Abstract][Full Text] [Related]
22. [Consensus guideline on the contents of clinical trial protocols].
López A; Costa J
Med Clin (Barc); 2013 Aug; 141(4):161-2. PubMed ID: 23540380
[No Abstract] [Full Text] [Related]
23. [Advanced Prostate Cancer Consensus Conference 2017 : Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts].
Schostak M; König F; Bögemann M; Goebell P; Hammerer P; Machtens S; Schwentner C; Thomas C; von Amsberg G; von Rundstedt FC; Heidenreich A
Urologe A; 2018 Jul; 57(7):813-820. PubMed ID: 29808368
[TBL] [Abstract][Full Text] [Related]
24. Developing a core outcome set for people living with dementia at home in their neighbourhoods and communities: study protocol for use in the evaluation of non-pharmacological community-based health and social care interventions.
Harding AJE; Morbey H; Ahmed F; Opdebeeck C; Wang YY; Williamson P; Swarbrick C; Leroi I; Challis D; Davies L; Reeves D; Holland F; Hann M; Hellström I; Hydén LC; Burns A; Keady J; Reilly S
Trials; 2018 Apr; 19(1):247. PubMed ID: 29690920
[TBL] [Abstract][Full Text] [Related]
25. Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer-2019 Updates.
Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Kwong PW; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Ma WK
Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():12-26. PubMed ID: 33860645
[TBL] [Abstract][Full Text] [Related]
26. [Drug therapy of hormone-sensitive metastatic prostate cancer : Consensus paper of the AKO/AUO].
Ohlmann CH; Gschwend J; Miller K
Urologe A; 2016 Sep; 55(9):1164-72. PubMed ID: 27431813
[TBL] [Abstract][Full Text] [Related]
27. ESUR prostate MR guidelines.
Iu PP
Eur Radiol; 2013 Aug; 23(8):2320-1. PubMed ID: 23715772
[No Abstract] [Full Text] [Related]
28. [Not Available].
Zermann DH; Hoffmann W; Otto U
Urologe A; 2016 Jul; 55(7):940. PubMed ID: 27246472
[No Abstract] [Full Text] [Related]
29. [Certified prostate centers of the DVPZ : Current status].
Zumbe J; Berges R
Urologe A; 2010 Aug; 49(8):916-21. PubMed ID: 20652675
[TBL] [Abstract][Full Text] [Related]
30. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?
Descazeaud A; Rubin MA; Allory Y; Burchardt M; Salomon L; Chopin D; Abbou C; de la Taille A
Eur Urol; 2005 Dec; 48(6):911-5. PubMed ID: 16140457
[TBL] [Abstract][Full Text] [Related]
31. Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies.
Khalil A; Duffy JMN; Perry H; Ganzevoort W; Reed K; Baschat AA; Deprest J; Gratacos E; Hecher K; Lewi L; Lopriore E; Oepkes D; Papageorghiou A; Gordijn SJ;
Trials; 2019 Jan; 20(1):35. PubMed ID: 30626413
[TBL] [Abstract][Full Text] [Related]
32. [Rehabilitation of prostate cancer patients : A multidisciplinary consensus].
Rick O; Böckmann J; Dauelsberg T; Hoffmann W; Kämpfer W; Otto U; Rogge A; Zermann D
Urologe A; 2016 Jul; 55(7):933-9. PubMed ID: 27246473
[TBL] [Abstract][Full Text] [Related]
33. The critical limitations of volume-outcome analysis.
Ellison L
Urol Oncol; 2009; 27(4):422-6. PubMed ID: 19573773
[TBL] [Abstract][Full Text] [Related]
34. ESUR prostate MR guidelines. Author reply.
Barentsz J; Villers A; Schouten M
Eur Radiol; 2013 Aug; 23(8):2322-3. PubMed ID: 23754463
[No Abstract] [Full Text] [Related]
35. [S3 guideline for bladder cancer : Claim and reality - a critical commentary from the guideline coordinators].
Retz M; Maisch P; Gschwend JE
Urologe A; 2016 Sep; 55(9):1188-91. PubMed ID: 27581238
[No Abstract] [Full Text] [Related]
36. [The HAROW study: an example of outcomes research: a prospective, non-interventional study comparing treatment options in localized prostate cancer].
Herden J; Ernstmann N; Schnell D; Weißbach L
Urologe A; 2014 Dec; 53(12):1743-52. PubMed ID: 25412911
[TBL] [Abstract][Full Text] [Related]
37. Prostate Cancer and the John West Effect.
EAU-ESTRO-ESUR-SIOG Prostate Cancer Guidelines Panel
Eur Urol; 2017 Jul; 72(1):7-9. PubMed ID: 28385455
[TBL] [Abstract][Full Text] [Related]
38. COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults.
Duane S; Vellinga A; Murphy AW; Cormican M; Smyth A; Healy P; Moore M; Little P; Devane D
Trials; 2019 Feb; 20(1):106. PubMed ID: 30732617
[TBL] [Abstract][Full Text] [Related]
39. Development of prostate cancer quality indicators: a modified Delphi approach.
Gagliardi AR; Fleshner N; Langer B; Stern H; Brown AD
Can J Urol; 2005 Oct; 12(5):2808-15. PubMed ID: 16274516
[TBL] [Abstract][Full Text] [Related]
40. [Advanced Prostate Cancer Consensus Conference (APCCC) 2015 in St. Gallen : Critical review of the recommendations on diagnosis and therapy of metastatic prostate cancer by a German expert panel].
Thomas C; Bögemann M; König F; Machtens S; Schostak M; Steuber T; Heidenreich A
Urologe A; 2016 Jun; 55(6):772-82. PubMed ID: 26820660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
